Future efforts should prioritize dissecting EEF1A1-STAT1 interaction mechanisms and translating these findings into targeted therapies, such as STAT1 inhibitors or EEF1A1 modulators, to restore immune homeostasis in SLE. This evidence concerns the gene STAT1 and systemic lupus erythematosus.